ABSTRACT
Objective@#To investigate the clinical effect of Astragalus injection combined with meropenem in the treatment of severe infection patients and its influence on T lymphocyte subsets and inflammatory factors in peripheral blood.@*Methods@#From January 2016 to December 2018, 80 patients with severe infections in Yiwu Fuyuan Private Hospital were selected and divided into observation group (n=40) and control group (n=40) according to single blind random table method.The observation group was treated with Astragalus injection combined with meropenem, while the control group was treated with meropenem.Both two groups were treated for 10 days.The therapeutic effects, changes of body temperature, heart rate and respiratory rate, changes of T lymphocyte subsets and inflammatory factors in peripheral blood, and negative time of bacterial culture before and after treatment were compared between the two groups.@*Results@#The total effective rate of the observation group (92.50%) was higher than that of the control group (70.00%) (χ2=6.646, P<0.05). After treatment, the levels of CD3+ [(62.38±4.51)%], CD4+ [(40.63±2.15)%] and CD4+ /CD8+ (1.63±0.18) in the observation group were higher than those in the control group [(57.27±3.19)%, (35.47±1.93)% and (1.30±0.21)] (t=5.850, 11.296, 7.546, all P<0.05). After treatment, the levels of CRP [(28.79±8.74)mg/L], PCT [(0.56±0.12)g/L] and TNF-α [(157.93±20.47)pg/mL] in the observation group were lower than those in the control group [(43.71±12.67)mg/L, (1.10±0.23)g/L and (247.16±34.64)pg/mL] (t=13.640, 13.165, 14.026, all P<0.05). The negative turning time of bacterial culture in the observation group [(4.36±1.29)d] was shorter than that in the control group [(7.43±1.57)d] (t=9.493, P<0.05).@*Conclusion@#Astragalus membranaceus injection combined with meropenem has significant clinical effect in the treatment of patients with severe infections.It can improve cellular immune function and reduce inflammatory reaction, which is worthy of clinical reference.
ABSTRACT
Objective To investigate the clinical effect of Astragalus injection combined with meropenem in the treatment of severe infection patients and its influence on T lymphocyte subsets and inflammatory factors in peripheral blood.Methods From January 2016 to December 2018,80 patients with severe infections in Yiwu Fuyuan Private Hospital were selected and divided into observation group (n＝40) and control group (n＝40) according to single blind random table method.The observation group was treated with Astragalus injection combined with meropen-em,while the control group was treated with meropenem.Both two groups were treated for 10 days.The therapeutic effects,changes of body temperature ,heart rate and respiratory rate ,changes of T lymphocyte subsets and inflammatory factors in peripheral blood ,and negative time of bacterial culture before and after treatment were compared between the two groups.Results The total effective rate of the observation group (92.50%) was higher than that of the control group (70.00%) (χ2 ＝6.646,P＜0.05).After treatment,the levels of CD +3 [(62.38 ±4.51)%],CD+4 [(40.63 ±2.15)%] and CD +4 ／CD+8 (1.63 ±0.18) in the observation group were higher than those in the control group [(57.27 ±3.19)%,(35.47 ±1.93)% and (1.30 ±0.21)] ( t＝5.850,11.296,7.546,all P＜0.05). After treatment,the levels of CRP [(28.79 ±8.74)mg／L],PCT [(0.56 ±0.12) g／L] and TNF-α[(157.93 ± 20.47) pg／mL] in the observation group were lower than those in the control group [(43.71 ±12.67) mg／L, (1.10 ±0.23) g／L and (247.16 ±34.64) pg／mL] ( t ＝13.640,13.165,14.026,all P ＜0.05).The negative turning time of bacterial culture in the observation group [(4.36 ±1.29)d] was shorter than that in the control group [(7.43 ±1.57) d] ( t＝9.493,P＜0.05).Conclusion Astragalus membranaceus injection combined with mero-penem has significant clinical effect in the treatment of patients with severe infections .It can improve cellular immune function and reduce inflammatory reaction ,which is worthy of clinical reference.